Literature DB >> 3760825

Dissociation of the haemagglutination inhibition and the infectivity neutralization in the reactions of influenza A/USSR/90/77 (H1N1) virus variants with monoclonal antibodies.

A K Gitelman, N V Kaverin, I G Kharitonenkov, I A Rudneva, E L Sklyanskaya, V M Zhdanov.   

Abstract

Variants of influenza A/USSR/90/77 (H1N1) virus selected with monoclonal antibody HC 142 (Res 142-1 and Res 142-2) were resistant to this antibody in a virus-neutralization (VN) test, but were inhibited in a haemagglutination-inhibition (HI) test. A variant selected with HC 22 monoclonal antibody (Res 22) was resistant to HC 142 only in VN tests. A mouse-adapted variant of A/USSR/90/77, shown previously to be resistant to HC 22, reacted with HC 142 in a manner similar to that of Res 142-1, Res 142-2 and Res 22. Another monoclonal antibody, HC 125, behaved similarly to HC 142. The addition of anti-immunoglobulin serum restored the ability of HC 142 and HC 125 (already bound to the virus) to neutralize the infectivity of the resistant variants. Polyacrylamide gel electrophoresis revealed differences in the mobility of haemagglutinin among the variants.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3760825     DOI: 10.1099/0022-1317-67-10-2247

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  13 in total

Review 1.  Insights into neutralization of animal viruses gained from study of influenza virus.

Authors:  M C Outlaw; N J Dimmock
Journal:  Epidemiol Infect       Date:  1991-04       Impact factor: 2.451

2.  Preexisting Immunity, More Than Aging, Influences Influenza Vaccine Responses.

Authors:  Adrian J Reber; Jin Hyang Kim; Renata Biber; H Keipp Talbot; Laura A Coleman; Tatiana Chirkova; F Liaini Gross; Evelene Steward-Clark; Weiping Cao; Stacie Jefferson; Vic Veguilla; Eric Gillis; Jennifer Meece; Yaohui Bai; Heather Tatum; Kathy Hancock; James Stevens; Sarah Spencer; Jufu Chen; Paul Gargiullo; Elise Braun; Marie R Griffin; Maria Sundaram; Edward A Belongia; David K Shay; Jacqueline M Katz; Suryaprakash Sambhara
Journal:  Open Forum Infect Dis       Date:  2015-04-15       Impact factor: 3.835

3.  Neutralization map of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus: domains recognized by monoclonal antibodies that prevent receptor recognition.

Authors:  R M Iorio; R J Syddall; J P Sheehan; M A Bratt; R L Glickman; A M Riel
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

4.  Rapid focus reduction neutralization test of influenza A and B viruses in microtiter system.

Authors:  Y Okuno; K Tanaka; K Baba; A Maeda; N Kunita; S Ueda
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

Review 5.  Virulence of influenza A virus for mouse lung.

Authors:  A C Ward
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

6.  Studies on the genetic basis of human influenza A virus adaptation to mice: degrees of virulence of reassortants with defined genetic content.

Authors:  N V Kaverin; N N Finskaya; I A Rudneva; A K Gitelman; I G Kharitonenkov; Y A Smirnov
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

Review 7.  Viva la revolución: rethinking influenza a virus antigenic drift.

Authors:  Jonathan W Yewdell
Journal:  Curr Opin Virol       Date:  2011-09       Impact factor: 7.090

8.  Changes in the hemagglutinin gene of the neurovirulent influenza virus strain A/NWS/33.

Authors:  A C Ward; T F de Koning-Ward
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

9.  Structural differences among hemagglutinins of influenza A virus subtypes are reflected in their antigenic architecture: analysis of H9 escape mutants.

Authors:  Nikolai V Kaverin; Irina A Rudneva; Natalia A Ilyushina; Aleksandr S Lipatov; Scott Krauss; Robert G Webster
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

10.  Neutralization enzyme immunoassay for influenza virus.

Authors:  C A Benne; M Harmsen; J C De Jong; C A Kraaijeveld
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.